<i>G. mellonella</i> health index scoring system (HISS). حسب Umaru Bah (20421789)

الموضوعات:

Screening flowchart. حسب Xuechun Fan (5439470)

"…<div><p>Introduction</p><p>Diabetic peripheral neuropathy (DPN), a prevalent complication among individuals diagnosed with type 2 diabetes, has a significant impact on both the well-being of patients and their financial situation. …"

Search strategy in PubMed. حسب Xuechun Fan (5439470)

"…<div><p>Introduction</p><p>Diabetic peripheral neuropathy (DPN), a prevalent complication among individuals diagnosed with type 2 diabetes, has a significant impact on both the well-being of patients and their financial situation. …"

<i>LGALS3</i> silencing reduces the neutral fat accumulation in 3D spheroids. حسب Francesca Sedda (16021610)

<i>LGALS3</i> silencing reduces collagen type I secretion. حسب Francesca Sedda (16021610)

<i>LGALS3</i> expression trends in MASLD and HCC. حسب Francesca Sedda (16021610)

Cell viability is not affected following <i>LGALS3</i> silencing. حسب Francesca Sedda (16021610)

Safety assessment of EBL in zebrafish larvae identifies a non-adverse exposure. حسب Zhuangbin Zheng (22676304)

ABTS assay of EBL. حسب Zhuangbin Zheng (22676304)

Comparison of anti-RBD IgG antibody levels against SARS-CoV-2 at baseline, monitoring 1 (Mon-1; 4–5 weeks post-baseline) and monitoring 2 (Mon-2; 8–9 weeks post-baseline) in the po... حسب Jajah Fachiroh (4350907)

Data Sheet 3_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Data Sheet 4_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Table 4_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.xlsx حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Data Sheet 1_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Table 2_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.xlsx حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Data Sheet 2_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Table 3_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.xlsx حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Table 1_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.xlsx حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Poor association between IgM-NS1 antibodies and CZS-related microcephaly. حسب Sebastián Castro-Trujillo (20513837)

Association between IgG-NS1 antibodies and CZS-related microcephaly. حسب Sebastián Castro-Trujillo (20513837)